These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7509745)

  • 21. Bifunctional intercalator [N-MeCys3,N-MeCys7]TANDEM binds to the dinucleotide TpA.
    Waterloh K; Olsen RK; Fox KR
    Biochemistry; 1992 Jul; 31(27):6246-53. PubMed ID: 1320932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of the cobalt complex of a bleomycin functional model with d(CGCAATTGCG)2: evidence of minor groove binding by 2D NMR methods.
    Yang Y; Huang L; Pon RT; Lown JW
    Biochem Biophys Res Commun; 1995 Jul; 212(3):995-1000. PubMed ID: 7542892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of bleomycin-induced DNA double-strand breaks: predominance of blunt ends and single-base 5' extensions.
    Povirk LF; Han YH; Steighner RJ
    Biochemistry; 1989 Jul; 28(14):5808-14. PubMed ID: 2476175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence-specific recognition and cleavage of DNA by metallobleomycin: minor groove binding and possible interaction mode.
    Kuwahara J; Sugiura Y
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2459-63. PubMed ID: 2451823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of intercalation-induced changes in DNA structure by reaction with diethyl pyrocarbonate or potassium permanganate. Evidence against the induction of Hoogsteen base pairing by echinomycin.
    Jeppesen C; Nielsen PE
    FEBS Lett; 1988 Apr; 231(1):172-6. PubMed ID: 3360122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The determination of the DNA sequence specificity of bleomycin-induced abasic sites.
    Chen JK; Murray V
    J Biol Inorg Chem; 2016 Jun; 21(3):395-406. PubMed ID: 26940956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of iron, copper, cobalt, and their chelators on the cytotoxicity of bleomycin.
    Lin PS; Kwock L; Hefter K; Misslbeck G
    Cancer Res; 1983 Mar; 43(3):1049-53. PubMed ID: 6186368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cleavage of a double-stranded DNA target by bleomycin derivatives of oligonucleotides, forming a ternary complex].
    Sergeev DS; Godovikova TS; Zarytova VF
    Bioorg Khim; 1995 Mar; 21(3):188-96. PubMed ID: 7539268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the antitumor antibiotic mithramycin on the structure of repetitive DNA regions adjacent to its GC-rich binding site.
    Cons BM; Fox KR
    Biochemistry; 1991 Jun; 30(25):6314-21. PubMed ID: 1829382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence-selective binding of phleomycin to DNA.
    Fox KR; Grigg GW; Waring MJ
    Biochem J; 1987 May; 243(3):847-51. PubMed ID: 2444208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Origin of sequence specific cleavage of DNA by bleomycins.
    Kuroda R; Shinomiya M; Otsuka M
    Nucleic Acids Symp Ser; 1992; (27):9-10. PubMed ID: 1283919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleomycin versus OH-radical-induced malonaldehydic-product formation in DNA.
    Rashid R; Langfinger D; Wagner R; Schuchmann HP; von Sonntag C
    Int J Radiat Biol; 1999 Jan; 75(1):101-9. PubMed ID: 9972796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genome-wide DNA sequence specificity of the anti-tumour drug bleomycin in human cells.
    Murray V; Chen JK; Tanaka MM
    Mol Biol Rep; 2016 Jul; 43(7):639-51. PubMed ID: 27188426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Footprinting studies on the interactions of nogalamycin, arugomycin, decilorubicin and viriplanin with DNA.
    Fox KR
    Anticancer Drug Des; 1988 Dec; 3(3):157-68. PubMed ID: 3207463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA sequence recognition by bleomycin.
    Fox KR
    Anticancer Drug Des; 1990 Feb; 5(1):99-104. PubMed ID: 1690547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for the metal binding domain in determining the DNA sequence selectivity of Fe-bleomycin.
    Carter BJ; Murty VS; Reddy KS; Wang SN; Hecht SM
    J Biol Chem; 1990 Mar; 265(8):4193-6. PubMed ID: 1689722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement and alteration of bleomycin-catalyzed site-specific DNA cleavage by distamycin A and some minor groove binders.
    Yamamoto K; Kawanishi S
    Biochem Biophys Res Commun; 1992 Feb; 183(1):292-9. PubMed ID: 1371920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence selective binding of bis-daunorubicin WP631 to DNA.
    Fox KR; Webster R; Phelps RJ; Fokt I; Priebe W
    Eur J Biochem; 2004 Sep; 271(17):3556-66. PubMed ID: 15317591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of key analogs of bleomycin A2 that permit a systematic evaluation of the linker region: identification of an exceptionally prominent role for the L-threonine substituent.
    Boger DL; Colletti SL; Teramoto S; Ramsey TM; Zhou J
    Bioorg Med Chem; 1995 Sep; 3(9):1281-95. PubMed ID: 8564421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleomycin-induced DNA lesions at mutational hot spots: implications for the mechanism of double-strand cleavage.
    Steighner RJ; Povirk LF
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8350-4. PubMed ID: 1700429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.